Cerity Partners LLC Applied Therapeutics Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 34,337 shares of APLT stock, worth $13,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,337Holding current value
$13,734% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
114Shares Held
115MCall Options Held
827KPut Options Held
524K-
Vestal Point Capital, LP New York, NY11.5MShares$4.6 Million0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$4.15 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$4 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$3.85 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$3.53 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $19.2M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...